Profil
Gunnar Ahlberg currently works at GHP Stockholm Gastro Center AB, as Chief Executive Officer and Sciety AB, as Director & Medical Director.
Dr. Ahlberg also formerly worked at GHP Specialty Care AB, as Chief Medical Officer from 2020 to 2023.
Dr. Ahlberg received his doctorate degree from Karolinska Institutet.
Postes actifs de Gunnar Ahlberg
| Sociétés | Poste | Début |
|---|---|---|
Sciety AB
Sciety AB Investment ManagersFinance Sciety invests in companies located in Sweden. The firm targets companies operating in the fields of biotechnology, medical technology, pharmacology, diagnostics, ICT in healthcare and health tech. It provides financing for early stage capital requirements with an investment size of EUR 1 - 15 million for initial investments and up to EUR 30 million for follow on investments. The firm makes co-investments and also makes follow on investments. | Directeur Technique/Scientifique/R&D | - |
GHP Stockholm Gastro Center AB
GHP Stockholm Gastro Center AB Medical/Nursing ServicesHealth Services Operates specialist clinics | Directeur Général | - |
Anciens postes connus de Gunnar Ahlberg
| Sociétés | Poste | Fin |
|---|---|---|
| GHP SPECIALTY CARE AB (PUBL) | Directeur Technique/Scientifique/R&D | 01/07/2023 |
Formation de Gunnar Ahlberg
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Karolinska Institutet
Karolinska Institutet Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GHP Specialty Care AB
GHP Specialty Care AB Medical/Nursing ServicesHealth Services Provides healthcare services | Health Services |
GHP Stockholm Gastro Center AB
GHP Stockholm Gastro Center AB Medical/Nursing ServicesHealth Services Operates specialist clinics | Health Services |
Sciety AB
Sciety AB Investment ManagersFinance Sciety invests in companies located in Sweden. The firm targets companies operating in the fields of biotechnology, medical technology, pharmacology, diagnostics, ICT in healthcare and health tech. It provides financing for early stage capital requirements with an investment size of EUR 1 - 15 million for initial investments and up to EUR 30 million for follow on investments. The firm makes co-investments and also makes follow on investments. | Finance |
















